The Gaithersburg City Council approved unanimously approved Novavax’s development plan at Monday’s meeting.
Per Shulman Rogers, Novavax secured two sites in the City of Gaithersburg and obtained zoning approvals for a 180,000 square feet Global Headquarters and manufacturing facility delivering late summer at 700 Quince Orchard, and an additional 600,000+ square feet integrated campus next door at 14 Firstfield Road for expansion of its manufacturing and research and development capacity.
Last year, the State of Maryland announced it would assist with project costs related to the expansion. The Maryland Department of Commerce approved a $2 million conditional loan contingent on job creation and capital investment. In addition, the state approved a $200,000 Partnership for Workforce Quality training grant, and the company was deemed eligible for several tax credits, including the Job Creation Tax Credit and More Jobs for Marylanders.
Montgomery County approved a $500,000 grant, contingent on job creation and capital investment, and the City of Gaithersburg is anticipated to approve a grant of up to $50,000 from its Economic Development Opportunity Fund.
Over 400 jobs are expected by December 2024.